Ulrich Koller

1.4k total citations
55 papers, 1.0k citations indexed

About

Ulrich Koller is a scholar working on Molecular Biology, Cell Biology and Biotechnology. According to data from OpenAlex, Ulrich Koller has authored 55 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 34 papers in Cell Biology and 13 papers in Biotechnology. Recurrent topics in Ulrich Koller's work include Skin and Cellular Biology Research (33 papers), RNA regulation and disease (21 papers) and Transgenic Plants and Applications (13 papers). Ulrich Koller is often cited by papers focused on Skin and Cellular Biology Research (33 papers), RNA regulation and disease (21 papers) and Transgenic Plants and Applications (13 papers). Ulrich Koller collaborates with scholars based in Austria, Germany and United States. Ulrich Koller's co-authors include Johann Bauer, Eva M. Murauer, Stefan Hainzl, Thomas Köcher, Julia Reichelt, Verena Wally, Alfred Klausegger, Patricia Peking, Johannes Bischof and Helmut Hintner and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Advanced Drug Delivery Reviews.

In The Last Decade

Ulrich Koller

52 papers receiving 1.0k citations

Peers

Ulrich Koller

GENET

BIOTE

BIOMA

Stefan Hainzl Austria

Eva M. Murauer Austria

Verena Wally Austria

Lily Xia United States

Laura De Rosa Italy

Yingping Hou United States

Beau R. Webber United States

Yannick Gache France

Hongmin Tu Finland

Satoru Shinkuma Japan

Stefan Hainzl Austria

Ulrich Koller

579 ×0.9

395 ×0.7

172 ×0.8

GENET

128 ×0.7

BIOTE

101 ×0.6

BIOMA

Citations per year, relative to Ulrich Koller Ulrich Koller (= 1×) peers Stefan Hainzl

Countries citing papers authored by Ulrich Koller

Since Specialization

Citations

This map shows the geographic impact of Ulrich Koller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrich Koller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrich Koller more than expected).

Fields of papers citing papers by Ulrich Koller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrich Koller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrich Koller. The network helps show where Ulrich Koller may publish in the future.

Co-authorship network of co-authors of Ulrich Koller

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrich Koller. A scholar is included among the top collaborators of Ulrich Koller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrich Koller. Ulrich Koller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ablinger, Michael, et al.. (2025). Transcriptome-guided drug repurposing identifies selumetinib for an aggressive epithelial cancer. Journal of Investigative Dermatology.

Hainzl, Stefan, Johannes Bischof, Thomas Köcher, et al.. (2024). Splicing Modulation via Antisense Oligonucleotides in Recessive Dystrophic Epidermolysis Bullosa. International Journal of Molecular Sciences. 25(2). 761–761. 5 indexed citations

Bischof, Johannes, et al.. (2024). Emerging Gene Therapeutics for Epidermolysis Bullosa under Development. International Journal of Molecular Sciences. 25(4). 2243–2243. 17 indexed citations

Klermund, Julia, Manuel Rhiel, Thomas Köcher, et al.. (2024). On- and off-target effects of paired CRISPR-Cas nickase in primary human cells. Molecular Therapy. 32(5). 1298–1310. 35 indexed citations

Neureiter, Daniel, Marlena Beyreis, Markus Ritter, et al.. (2023). Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer. Cancers. 15(5). 1569–1569. 13 indexed citations

Köcher, Thomas, Stefan Hainzl, Johannes Bischof, et al.. (2023). A Novel Fluorescence-Based Screen of Gene Editing Molecules for Junctional Epidermolysis Bullosa. International Journal of Molecular Sciences. 24(6). 5197–5197. 1 indexed citations

Bischof, Johannes, Thomas Köcher, Stefan Hainzl, et al.. (2022). COL17A1 editing via homology-directed repair in junctional epidermolysis bullosa. Frontiers in Medicine. 9. 976604–976604. 16 indexed citations

Köcher, Thomas & Ulrich Koller. (2021). Advances in gene editing strategies for epidermolysis bullosa. Progress in molecular biology and translational science. 182. 81–109. 6 indexed citations

Köcher, Thomas, Johannes Bischof, Stefan Hainzl, et al.. (2020). Predictable CRISPR/Cas9-Mediated COL7A1 Reframing for Dystrophic Epidermolysis Bullosa. Journal of Investigative Dermatology. 140(10). 1985–1993.e5. 29 indexed citations

10.

Köcher, Thomas, et al.. (2020). Context-Dependent Strategies for Enhanced Genome Editing of Genodermatoses. Cells. 9(1). 112–112. 25 indexed citations

11.

Bornert, Olivier, Pauline Nauroy, Johannes Bischof, et al.. (2020). QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study. Journal of Investigative Dermatology. 141(4). 883–893.e6. 40 indexed citations

12.

Lettner, Thomas, Alfred Klausegger, Michael Ablinger, et al.. (2019). Gene Editing–Mediated Disruption of Epidermolytic Ichthyosis–Associated KRT10 Alleles Restores Filament Stability in Keratinocytes. Journal of Investigative Dermatology. 139(8). 1699–1710.e6. 27 indexed citations

13.

Köcher, Thomas, Roland N. Wagner, Alfred Klausegger, et al.. (2019). Improved Double-Nicking Strategies for COL7A1-Editing by Homologous Recombination. Molecular Therapy — Nucleic Acids. 18. 496–507. 36 indexed citations

14.

Bornert, Olivier, Thomas Köcher, Christine Gretzmeier, et al.. (2019). Generation of rabbit polyclonal human and murine collagen VII monospecific antibodies: A useful tool for dystrophic epidermolysis bullosa therapy studies. SHILAP Revista de lepidopterología. 4. 100017–100017. 18 indexed citations

15.

Peking, Patricia, Ulrich Koller, & Eva M. Murauer. (2017). Functional therapies for cutaneous wound repair in epidermolysis bullosa. Advanced Drug Delivery Reviews. 129. 330–343. 10 indexed citations

16.

Peking, Patricia, Ulrich Koller, Blanca Duarte, et al.. (2017). An RNA-targeted therapy for dystrophic epidermolysis bullosa. Nucleic Acids Research. 45(17). 10259–10269. 22 indexed citations

17.

Köcher, Thomas, Stefan Hainzl, Julia Reichelt, et al.. (2016). Construction and validation of an RNA trans-splicing molecule suitable to repair a large number of COL7A1 mutations. Gene Therapy. 23(11). 775–784. 29 indexed citations

18.

Guttmann‐Gruber, Christina, Iris K. Gratz, Eva M. Murauer, et al.. (2011). Spliceosome-Mediated RNA Trans -Splicing Facilitates Targeted Delivery of Suicide Genes to Cancer Cells. Molecular Cancer Therapeutics. 10(2). 233–241. 24 indexed citations

19.

Koller, Ulrich, Verena Wally, Lloyd G. Mitchell, et al.. (2011). A novel screening system improves genetic correction by internal exon replacement. Nucleic Acids Research. 39(16). e108–e108. 28 indexed citations

20.

Wally, Verena, Alfred Klausegger, Ulrich Koller, et al.. (2007). 5′ Trans-Splicing Repair of the PLEC1 Gene. Journal of Investigative Dermatology. 128(3). 568–574. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact